Skip to main content
Robert Stanton, MD, Internal Medicine, Boston, MA

RobertCStantonMD

Internal Medicine Boston, MA

Nephrology

Associate Professor of Medicine, Harvard Medical School Chief, Kidney and Hypertension Section, Joslin Diabetes Center

Dr. Stanton is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Stanton's full profile

Already have an account?

  • Office

    1 Joslin Pl
    Renal Section, Joslin Diabetes Center
    Boston, MA 02215
    Phone+1 617-309-2477
    Fax+1 617-309-2467

Summary

  • Robert C. Stanton, MD is a highly accomplished nephrologist affiliated with Joslin Diabetes Center and Beth Israel Deaconess Medical Center in Boston, Massachusetts. He is the Chief of the Kidney and Hypertension Section at Joslin Diabetes Center.

    Specialties and Clinical Interests:

    Internal Medicine-Nephrology

    Diabetic Nephropathy
    Fluid, Acid-Base and Electrolyte Disorders
    General Nephrology
    Hypertension

    Education and Training:

    Medical Education: Hahnemann University School of Medicine
    Residency: Oregon Health & Science University Hospital
    Fellowships: Brigham & Women's Hospital and Tufts Medical Center

    Academic Appointments:

    Associate Professor of Medicine at Harvard Medical School

    Research Focus:

    Dr. Stanton's research primarily focuses on glucose 6-phosphate dehydrogenase (G6PD), an essential enzyme that plays a major role in regulating oxidative stress levels in cells. His work aims to understand the basic cellular mechanisms responsible for diabetic kidney disease, pancreatic beta cell death, and cardiovascular disease in people with diabetes. His research has led to new understanding of the central role of G6PD in normal physiology and pathophysiology.

    Clinical Practice:

    He provides care for patients with various kidney diseases, diabetes-related kidney issues, and hypertension.

    Teaching and Recognition:

    Dr. Stanton is actively involved in teaching at all levels, from students to faculty, and is routinely invited to lecture both nationally and internationally. He has received three Honorary Professorships from universities in China. Dr. Stanton has also been recognized as a Top Doctor by Boston Magazine for multiple years and has received an Award for Sustained Excellence in Teaching from Harvard Medical School.

    Dr. Stanton's work combines clinical care, research, and education, making him a prominent figure in the field of nephrology, particularly in relation to diabetes-related kidney complications.

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital
    Brigham and Women's Hospital/Massachusetts General HospitalFellowship, Nephrology, 1984 - 1987
  • Oregon Health & Science University (OHSU Health)
    Oregon Health & Science University (OHSU Health)Residency, Internal Medicine, 1980 - 1984
  • Drexel University College of Medicine
    Drexel University College of MedicineClass of 1980

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • MA State Medical License
    MA State Medical License 1984 - 2025
  • OR State Medical License
    OR State Medical License 1981 - 1985
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Nephrology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2011-2013
  • Super Doctor SuperDoctors.com

Publications & Presentations

PubMed

Journal Articles

  • Recruitment and food-retrieving behavior in Novomessor (Formicidae, Hymenoptera)  
    Holldobler B, Stanton R, Markl H, Behavioral Ecology and Sociobiology 4:163-181, 1978
  • A New Exocrine Gland in Novomessor (Hymenoptera:Formicidae) and its Possible Signficance as a Taxonomic Character  
    Holldobler B, Stanton R, Engel H., Psyche 83:32-41, 1976

Press Mentions

  • No Agreement on Antioxidant Use for Cardiovascular Risk in CKD
    No Agreement on Antioxidant Use for Cardiovascular Risk in CKDAugust 13th, 2024
  • Study Suggests Ways DPP-4 Inhibitor Might Prevent Kidney Disease
    Study Suggests Ways DPP-4 Inhibitor Might Prevent Kidney DiseaseJuly 23rd, 2018
  • New Agents, Novel Targets Show Promise for Diabetic Kidney Disease
    New Agents, Novel Targets Show Promise for Diabetic Kidney DiseaseMay 15th, 2017

Grant Support

  • Glucose 6-P Dehydrogenase And Diabetic ComplicationsNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2008
  • Glucose 6-P Dehydrogenase In Diabetic ComplicationsNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2005